Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.

NCT03944499 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Breast Cancer

Interventions

DRUG: FS-1502

Sponsor

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.